Autoactivation and activation of the cytochrome P450s

International Journal of Clinical Pharmacology and Therapeutics

Volumn 36, Issue 12, 1998, Pages 642-651

  Ekins, S ^a   Ring, B J ^a   Binkley, S N ^a   Hall, S D ^b   Wrighton, S A ^a  

^a ELI LILLY AND COMPANY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoactivation kinetics; CYP1A2; Cytochrome P450; Xenobiotics

Indexed keywords

CYTOCHROME P450; ETHOXYRESORUFIN DEETHYLASE;

ARTICLE; ENZYME ACTIVATION; ENZYME KINETICS; ESCHERICHIA COLI; HUMAN; LIVER MICROSOME; MICHAELIS MENTEN KINETICS;

CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME ACTIVATION; ESCHERICHIA COLI; HUMANS; KINETICS; MICROSOMES, LIVER;

EID: 0031743851     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Andersson T, Miners JO, Veronese ME, Birkett, DJ 1994 Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms. Br J Clin Pharmacol 38: 131-137
2. Barron LD, Hecht L, Wilson G 1997 The lubricant of life: a proposal that solvent water promotes extremely fast conformational fluctuations in mobile heteropolypeptide structure. Biochemistry 36: 13143-13147
3. Bertilsson L, Tomson T 1986 Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10-11-epoxide. Clin Pharmacokinet 11: 177-198
4. Bourrie M, Meunier V, Berger Y, Fabre G 1996 Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. J Pharmacol Exp Ther 277: 321-332
5. Craig DB, Arriaga E, Wong JCY, Lu H, Dovichi NJ 1997 Life and death of a single enzyme molecule. Anal Chem 70: 39-40
6. Darber D, Dell'Orto S, Mörike K, Wilkinson GR, Roden DM 1997 Dietary salt increases first-pass elimination of oral quinidine. Clin Pharmacol Ther 61: 292-300
7. Davies DS, Gigon PL, Gillette JR 1968 Sex differences in the kinetic constants for the N-demethylation of ethylmorphine by rat liver microsomes. Biochem Pharmacol 17: 1865-1872
8. Domanski TL, Liu J, Harlow GR, Halpert JR 1998 Analysis of four residues within substrate recognition site 4 of human cytochrome P450 3A4: role in steroid hydroxylase activity and α-napthoflavone stimulation. Arch Biochem Biophys 350: 223-232
9. Ekins S, Bravi G, Ring BJ, Gillespie TA, Gillespie JS, VandenBranden M, Wrighton SA, Wikel JH 1998 Three dimensional-quantitative structure activity relationship (3D-QSAR) analyses of substrates for CYP2B6. J Pharmacol Exp Ther
10. Ekins S, VandenBranden M, Ring BJ, Gillespie JS, Yang TJ, Gelboin HV, Wrighton SA 1998 Characterization of the expression and catalytic activity of human CYP2B6. Clin Pharmacol Ther
11. Ekins S, VandenBranden M, Ring BJ, Wrighton SA 1997 Examination of purported probes of human CYP2B6. Pharmacogenetics 7: 165-179
12. 1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicol Appl Pharmacol 141: 595-606
13. Gerlt JA, Kreevoy MM, Cleland WW, Frey PA 1997 Understanding enzymic catalysis; the importance of short, strong hydrogen bonds. Chem Biol 4: 259-267
14. Ghahramani P, Ellis SW, Lennard MS, Ramsay LE, Tucker GT 1997 Cytochromes P450 mediating the N-demethylation of amitriptyline. Br J Clin Pharmacol 43: 137-144
15. Grant DM, Campbell ME, Tang BK, Kalow W 1987 Biotransformation of caffeine by microsomes from human liver. Biochem Pharmacol 36: 1251-1260
16. He YA, He YQ, Szklarz GD, Halpert JR 1997 Identification of three key residues in substrate recognition site 5 of human cytochrome P450 3A4 by cassette and site-directed mutagenesis. Biochemistry 36: 8831-8839
17. Ingelman-Sundberg M, Hagbjork AL, Ueng YF, Yamazaki H, Guengerich FP 1996 High rates of substrate hydroxylation by human cytochrome P450 3A4 in reconstituted membraneous vesicles: influence of membrane charge. Biochem Biophys Res Commun 221: 318-322
18. Iwatsubo T, Hirota N, Oooie T, Suzuki H, Shimada N, Chiba K, Ishizaki T, Green CE, Tyson CA, Sugiyama Y 1997 Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. Pharmacol Ther 73: 147-171
19. Kerr BM, Thummel KE, Wurden CJ, Klein SM, Kroetz DL, Gonzalez FJ, Levy RH 1994 Human liver carbamazepine metabolism. Biochem Pharmacol 47: 1969-1979
20. Klibanov AM 1997 Why are enzymes less active in organic solvents than in water? Trends Biotechnol 15: 97-101
21. Kolev AP, Robinson RC, Friedman FK 1996 Cytochrome P450 conformation and substrate interactions as probed by CO binding kinetics. Biochimie 78: 706-713
22. Korzekwa KR, Krishnamachary N, Shou M, Ogai A, Parise RA, Rettie AE, Gonzalez, FJ, Tracy TS 1998 Evaluation of atypical cytochrome P450 kinetics with two-substrate-models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites. Biochemistry 37: 4137-4147
23. Lasker JM, Huang M-T, Conney AH 1982 In vivo activation of zoxazolamine metabolism by flavone. Science 216: 1419-1421
24. Macheras P, Argyrakis P, Polymilis C 1996 Fractal geometry, fractal kinetics and chaos en route to biopharmaceutical sciences. Eur J Drug Metab Pharmacokinet 21: 77-86
25. Mäenpää J, Hall SD, Ring BJ, Strom SC, Wrighton SA 1998 Human cytochrome P4503A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by α-napthoflavone, terfenadine and testosterone. Pharmacogenetics 8: 137-155
26. McLean MA, Yeom H, Sligar SG 1996 Carbon monoxide binding to cytochrome P450BM-3: Evidence for a substrate-dependent conformational change. Biochimie 78: 700-705
27. Modi S, Gilham DE, Sutcliffe MJ, Lian L-Y, Primrose WU, Wolf CR, Roberts GCK 1997 1-methyl-4-phenyl-1,2,36-tetrahydropyridine as a substrate of cytochrome P450 2D6: Allosteric effects of NADPH-Cytochrome P450 reductase. Biochemistry 36: 4461-4470
28. Nelsestuen GL, Martinez MB 1997 Steady state enzyme velocities that are independent of (enzyme): an important bevavior in many membrane and particle-bound states. Biochemistry 36: 9081-9086
29. Newsholme EA, Start C 1973 Regulation in metabolism. John Wiley and Sons, London
30. Oprea TI, Hummer G, Garcia AE 1997 Identification of a functional water channel in cytochrome P450 enzymes. Proc Natl Acad Sci 94: 2133-2138
31. Poornima CS, Dean PM 1995 hydration in drug design. 1. Multiple hydrogen-bonding features of water molecules in mediating protein-ligand interactions. J Comput-Aided Mol Design 9: 500-512
32. Rasmussen BB, Mäenpää J, Pelkonen O, Loft S, Poulsen HE, Lykkesfeldt J, Brosen K 1995 Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine. BrJ Clin Pharmacol 39: 151
33. Sandermann H, Pflugmacher D 1996 Induction of lipid-protein mismatch by xenobiotics: kinetic cooperativity. Biochim Biophys Acta 1300: 219-225
34. Schmider J, Greenblatt DJ, Harmatz JS, Shader RI 1996a Enzyme kinetic modelling as a tool to analyse the behaviour of cytochrome P450 catalysed reactions: application to amitryptyline N-demethylation. Br J Clin Pharmacol 41: 593-604
35. Schmider J, Greenblatt DJ, von Moltke LL, Harmatz JS, Duan SX, Karsov D, Shader RI 1996b Characterization of six in vitro reactions mediated by human cytochrome P450: application to the testing of cytochrome P450-directed antibodies. Pharmacology 52: 125-134
36. Schmider J, Greenblatt DJ, Von Moltke LL, Harmatz JS, Shader RI 1995 N-demethylation of amitriptyline in vitro: role of cytochrome P-450 3A (CYP3A) isoforms and effect of metabolic inhibitors. J Pharmacol Exp Ther 275: 592-597
37. Schmider J, Greenblatt DJ, Von Moltke LL, Shader RI 1996c Relationship of in vitro data on drug metabolism to in vivo pharmacokinetics and drug interactions: Implications for diazepam disposition in man. J Clin Psychopharmacol 16: 267-272
38. Schwab GE, Raucy JL, Johnson EF 1998 Modulation of rabbit and human hepatic cytochrome P450-catalyzed steroid hydroxylations by α-napthoflavone. Mol Pharmacol 33: 493-499
39. Segel IH 1993 Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems. John Wiley and Sons, New York
40. 5. Arch Biochem Biophys 348: 107-115
41. Shou M, Grogan J, Mancewicz JA, Krausz KW, Gonzalez FJ, Gelboin HV, Korzekwa KR 1994 Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site. Biochemistry 33: 6450-6455
42. Tan Y, Patten CJ, Smith T, Yang CS 1997 Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system. Arch Biochem Biophys 342: 82-91
43. Tassaneeyakul W, Mohamed Z, Birkett DJ, McManus ME, Veronese ME, Tukey RH, Quattrochi LC, Gonzalez FJ, Miners JO 1992 caffiene as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques. Pharmacogenetics 2: 173-183
44. Tetreau C, Di Primo C, Lange R, Tourbez H, Lavalette D 1997 Dynamics of carbon monoxide binding with cytochrome P-450. Biochemistry 36: 10262-102275
45. Ueng Y-F, Kuwabara T, Chun Y-J, Guengerich FP 1997 Cooperativity in oxidations catalyzed by cytochrome P450 3A4. Biochemistry 36: 370-381
46. 1 by bacterial recombinant human cytochrome P450 enzymes. Chem Res Toxicol 8: 218-225
47. Venkatakrishnan K, Greenblatt DJ, von Moltke LL, Schmider J, Harmatz JS, Shader RI 1998a Distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP2C19 and 3A4. J Clin Pharmacol 38: 112-121
48. Venkatakrishnan K, von Moltke LL, Duan SX, Fleishaker JC, Shader RI, Greenblatt DJ 1998b Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man. J Pharm Pharmacol 50: 265-274
49. Weiss JN 1997 The Hill equation revisited: uses and misuses. FASEB J 11: 835-841
50. Witherow LE, Houston JB 1997 Sigmoidal kinetics of CYP3A4 substrates: An approach for scaling dextromethorphan metabolism in rat microsomes and isolated hepatocytes to predict in vivo clearance. ISSX Proc 12: 26
51. Wrighton SA, Vandenbranden M, Stevens JC, Shipley LA, King BJ 1993 In vitro methods for assessing human hepatic drug metabolism: their use in drug development. Drug Metab Rev 25: 453-84
52. 5 interactions. Arch Biochem Biophys 342: 329-337
53. Yamazaki H, Inui Y, Yun CH, Guengerich FP, Shimada T 1992 Cytochrome P4502E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosoamines in human liver microsomes. Carcinogenesis 13: 1789-1794
54. 5 in stimulation of catalytic activities of cytochrome P4503A4. J Biol Chem 44: 27438-27444
55. Yun C-H, Song M, Ahn T, Kim H 1996 Conformational change of cytochrome P450 1A2 induced by sodium chloride. J Biol Chem 49: 31312-31316